Alkem Labs Gains As U.S. FDA Conducts Audit At Daman Plant – Shares of the Mumbai-based drug maker rose as much as 2.1 percent t0 Rs 2,150 as U.S. drug regulator conducts a surprise audit at its largest facility in Daman, two people aware of the development told BloombergQuint requesting anonymity.
